104 related articles for article (PubMed ID: 2108838)
1. Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapy.
Johnson M; Shaw M; Rubenstein M; Guinan P
Clin Physiol Biochem; 1990; 8(1):11-5. PubMed ID: 2108838
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy using polyamine synthesis inhibitor alpha-difluoromethylornithine and adriamycin in treatment of rats carrying the Dunning R3327 MAT-LyLu prostatic adenocarcinoma.
Shaw MW; Guinan PD; McKiel CF; Dubin A; Rubenstein M
Prostate; 1987; 11(1):87-93. PubMed ID: 3116512
[TBL] [Abstract][Full Text] [Related]
3. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor.
Heston WD; Kadmon D; Covey DF; Fair WR
Cancer Res; 1984 Mar; 44(3):1034-40. PubMed ID: 6420052
[TBL] [Abstract][Full Text] [Related]
5. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G
Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653
[TBL] [Abstract][Full Text] [Related]
7. [Combination effect of flutamide and leuprorelin acetate on growth of Dunning R3327-H prostatic adenocarcinoma in rats].
Tomura A; Kuroiwa S; Okada M; Abe F
Gan To Kagaku Ryoho; 1998 Mar; 25(4):563-9. PubMed ID: 9530363
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpha-difluoromethylornithine on the growth of experimental Wilms' tumor and renal adenocarcinoma.
Kingsnorth AN; McCann PP; Diekema KA; Ross JS; Malt RA
Cancer Res; 1983 Sep; 43(9):4031-4. PubMed ID: 6307502
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory action of alpha-difluoromethylornithine on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis.
Uchida K; Seidenfeld J; Rademaker A; Oyasu R
Cancer Res; 1989 Oct; 49(19):5249-53. PubMed ID: 2504487
[TBL] [Abstract][Full Text] [Related]
11. In vivo, synergestic inhibition of MAT-LyLu rat prostatic adenocarcinoma growth by polyamine deprivation and low-dose cyclophosphamide.
Cipolla B; Blanchard Y; Chamaillard L; Quemener V; Guillé F; Havouis R; Moulinoux JP
Urol Res; 1996; 24(2):93-8; discussion 99. PubMed ID: 8740978
[TBL] [Abstract][Full Text] [Related]
12. Oral cyclophosphamide and oral hydroxyurea in the treatment of hormone refractory prostate cancer in rats.
Naik H; Lehr J; Akhtar A; Pienta K
Anticancer Res; 1994; 14(6B):2681-4. PubMed ID: 7872701
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
[TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice.
Herr HW; Kleinert EL; Conti PS; Burchenal JH; Whitmore WF
Cancer Res; 1984 Oct; 44(10):4382-5. PubMed ID: 6432312
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous alpha-difluoromethylornithine on the polyamine levels of normal tissue and a transplantable fibrosarcoma.
Grossie VB; Ota DM; Ajani JA; Nishioka K
Cancer Res; 1987 Apr; 47(7):1836-40. PubMed ID: 3102050
[TBL] [Abstract][Full Text] [Related]
16. Comparisons between sensitive and resistant human tumor cell lines regarding effects of polyamine depletion on chloroethylnitrosourea efficacy.
Seidenfeld J; Sprague WS
Cancer Res; 1990 Feb; 50(3):521-6. PubMed ID: 2137022
[TBL] [Abstract][Full Text] [Related]
17. Polyamine deprivation enhances antitumoral efficacy of chemotherapy.
Quemener V; Moulinoux JP; Havouis R; Seiler N
Anticancer Res; 1992; 12(5):1447-53. PubMed ID: 1444206
[TBL] [Abstract][Full Text] [Related]
18. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
[TBL] [Abstract][Full Text] [Related]
19. Some effects of inhibitors of polyamine synthesis on experimental prostatic cancer.
Dunzendorfer U; Releyea N; Whitmore WF; Fogh J; Balis ME
Arzneimittelforschung; 1984; 34(1):36-9. PubMed ID: 6422951
[TBL] [Abstract][Full Text] [Related]
20. [Combined therapy of polyamine antimetabolite and nitrosourea in human gastric cancer].
Fujimoto S; Shrestha RD; Ohta M; Igarashi K; Miyazaki M; Endoh F; Shimura T; Takahashi O; Kawata S; Kurihara M
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3016-20. PubMed ID: 3094457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
